Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis

Targeted therapies within the RAS/RAF/MEK/ERK signalling axis become increasingly popular, yet cross-talk and feedbacks in the signalling network lead to unexpected effects. Here we look systematically into how inhibiting RAF and MEK with clinically relevant inhibitors result in changes in PI3K/AKT...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritsche-Guenther, Raphaela, Witzel, Franziska, Kempa, Stefan, Brummer, Tilman, Sers, Christine, Blüthgen, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884967/
https://www.ncbi.nlm.nih.gov/pubmed/26799289
http://dx.doi.org/10.18632/oncotarget.6959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884967/
https://www.ncbi.nlm.nih.gov/pubmed/26799289
http://dx.doi.org/10.18632/oncotarget.6959

Ejemplares similares